Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Yuya Ise"'
Autor:
Daisuke Hayashi, Yoshiaki Kubota, Takuya Nishino, Yukihiro Watanabe, Yoshiki Iwade, Junya Matsuda, Katsuhito Kato, Shuhei Tara, Yuya Ise, Yu-ki Iwasaki, Kuniya Asai
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 10, Iss 1, Pp 1-8 (2024)
Abstract Background Guideline-directed medical therapy (GDMT) is important in heart failure management; however, polypharmacy itself may impact heart failure. Although measures against polypharmacy are needed, current discussion on unilateral drug ta
Externí odkaz:
https://doaj.org/article/d42cfc734c3f43398cd72350238e07b4
Autor:
Yoshiki Iwade, Yoshiaki Kubota, Daisuke Hayashi, Takuya Nishino, Yukihiro Watanabe, Katsuhito Kato, Shuhei Tara, Yuya Ise, Kuniya Asai
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 10, Iss 1, Pp 1-6 (2024)
Abstract Background Pimobendan reportedly improves the subjective symptoms of heart failure. However, evidence of improved prognosis is lacking. This study aimed to determine whether reinforcing guideline-directed medical therapy (GDMT) improved reho
Externí odkaz:
https://doaj.org/article/e95f127bf97745f58b0bb52c3db9794e
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 9, Iss 1, Pp 1-5 (2023)
Abstract Background We aimed to evaluate the factors associated with baloxavir prescription in Japanese hospitals using a health insurance claim-based database (MDV analyzer), during the 2018/2019 and 2019/2020 influenza seasons. The MDV analyzer con
Externí odkaz:
https://doaj.org/article/92d4aa7a4aec4af0b5f04fb4fd2d65c6
Autor:
Shunsuke Inage, Ryo Yajima, Shintaro Nagahara, Aya Kazama, Moe Takamura, Tomohiro Shoji, Mika Kadoi, Yukiko Tashiro, Yuya Ise
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 8, Iss 1, Pp 1-8 (2022)
Abstract Background Acetaminophen-induced hypotension has been reported in critically ill patients; however, it remains unclear whether mannitol, present as a stabilizing compound in acetaminophen formulations, affects hemodynamic changes. The object
Externí odkaz:
https://doaj.org/article/8751227b91b043b98801c9b93116dc6a
Publikováno v:
Journal of Arrhythmia, Vol 36, Iss 6, Pp 1032-1038 (2020)
Abstract Background Information on apixaban anticoagulant activity is required to prevent major bleeding or thrombosis during its use. Methods We enrolled 194 patients with nonvalvular atrial fibrillation (NVAF) in whom warfarin was replaced with api
Externí odkaz:
https://doaj.org/article/02e80e62a0b6479bbfc95ddbb0484287
Publikováno v:
Nihon Ika Daigaku Igakkai Zasshi. 19:164-170
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d279827f2edb2b0ceaf7d971b19b6daf
https://doi.org/10.1272/manms.19.164
https://doi.org/10.1272/manms.19.164
Publikováno v:
Nihon Ika Daigaku Igakkai Zasshi. 18:282-288
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68a34ac0fe3520ebc87dc55633fc3bda
https://doi.org/10.1272/manms.18.282
https://doi.org/10.1272/manms.18.282
Publikováno v:
Journal of Arrhythmia
Journal of Arrhythmia, Vol 36, Iss 6, Pp 1032-1038 (2020)
Journal of Arrhythmia, Vol 36, Iss 6, Pp 1032-1038 (2020)
Background Information on apixaban anticoagulant activity is required to prevent major bleeding or thrombosis during its use. Methods We enrolled 194 patients with nonvalvular atrial fibrillation (NVAF) in whom warfarin was replaced with apixaban: 10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69690f266600d8362b5918f55f4fea6f
http://europepmc.org/articles/PMC7733564
http://europepmc.org/articles/PMC7733564
Autor:
Akiko Yamashiro, Masashi Kato, Yuichi Shinada, Yuya Ise, Nobuya Akizuki, Yoko Nakazawa, Mikiko Kaizu, Akihiro Sakashita, Hirofumi Abo, Koji Sugano
Publikováno v:
Journal of Palliative Medicine. 23:359-367
Background: The number of hospital-based palliative care consultation teams (PCCTs) has increased in Japan, and quality improvement (QI) of PCCTs is an issue. The Japanese Society for Palliative Medicine is building a framework for continuous QI of P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::925c4961c67262bcf890aaba92ca5118
https://doi.org/10.1089/jpm.2019.0236
https://doi.org/10.1089/jpm.2019.0236
Autor:
Inage, Shunsuke, Nakamura, Shotaro, Isoe, Yuto, Okamoto, Saori, Uetake, Sho, Murakami, Misato, Yamaguchi, Ayaka, Morishima, Masayo, Nei, Takahito, Ise, Yuya, Katayama, Shiro, Shunsuke, Inage, Shotaro, Nakamura, Yuto, Isoe, Saori, Okamoto, Sho, Uetake, Misato, Murakami, Ayaka, Yamaguchi, Masayo, Morishima, Takahito, Nei, Yuya, Ise, Shiro, Katayama
Publikováno v:
Journal of Nippon Medical School. 87(2):66-72
Background We investigated the incidence of acute kidney injury (AKI) and risk factors associated with vancomycin (VAN) and piperacillin-tazobactam (TZP) combination therapy in non-intensive care unit (ICU) and ICU settings. Methods In this single-ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::463bfd8f9654998a891a4448a15b1a41
http://id.nii.ac.jp/1645/00000465/
http://id.nii.ac.jp/1645/00000465/